This feat is a first of its kind that we have initiated. Congratulating the team, Dr Alok Khullar, CEO, GGHC, and Anurag Yadav, CEO, IHH Health Care India, said, One in 5,000 women in the country suffers from uterus-factor infertility. With commercial surrogacy banned in India, such transplant offers women an opportunity to become mothers and experience the joy of motherhood on their own, Dr Padmapriya said and added that child birth is the ultimate aim of this transplant.